Fig. 3

The mean plasma concentration–time profiles of bergapten after oral (a) and intravenous (b) administration (n = 8, mean ± SD)
The mean plasma concentration–time profiles of bergapten after oral (a) and intravenous (b) administration (n = 8, mean ± SD)